Published in Nature on July 27, 1978
Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther (2008) 2.47
Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. Br J Pharmacol (1983) 1.96
In Vivo Measurement of GABA Transmission in Healthy Subjects and Schizophrenia Patients. Am J Psychiatry (2015) 1.51
Brain tumors. West J Med (1991) 1.44
Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav (2008) 1.36
Combined discriminative stimulus effects of midazolam with other positive GABAA modulators and GABAA receptor agonists in rhesus monkeys. Psychopharmacology (Berl) (2004) 1.10
Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects. Neuropsychopharmacology (2008) 1.03
beta-Carbolines enhance shock-induced suppression of drinking in rats. Proc Natl Acad Sci U S A (1983) 1.02
Biochemical dissection of the gamma-aminobutyrate synapse. Biochem J (1983) 0.99
Micromolar-affinity benzodiazepine receptors regulate voltage-sensitive calcium channels in nerve terminal preparations. Proc Natl Acad Sci U S A (1984) 0.96
Augmentation by chlordiazepoxide of the inhibitory effects of taurine, beta-alanine and gamma-aminobutyric acid on spike discharges in guinea-pig cerebellar slices. Br J Pharmacol (1979) 0.94
Stimulation of benzodiazepine receptor binding by gamma-aminobutyric acid. Proc Natl Acad Sci U S A (1979) 0.94
Impact of species variability and 'probe-dependence' on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor. Br J Pharmacol (2011) 0.93
Individually monitoring ligand-induced changes in the structure of the GABAA receptor at benzodiazepine binding site and non-binding-site interfaces. Mol Pharmacol (2008) 0.93
Regulation of G protein-coupled receptors by allosteric ligands. ACS Chem Neurosci (2013) 0.87
Awake nonhuman primate brain PET imaging with minimal head restraint: evaluation of GABAA-benzodiazepine binding with 11C-flumazenil in awake and anesthetized animals. J Nucl Med (2013) 0.86
[11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levels. PLoS One (2012) 0.84
The benzodiazepine receptor. Anesth Prog (1986) 0.83
Autoradiographic localization of benzodiazepine receptors in immunocytochemically identified gamma-aminobutyrergic synapses. Proc Natl Acad Sci U S A (1981) 0.83
Zolpidem reduces the blood oxygen level-dependent signal during visual system stimulation. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.82
Structure-activity studies on the potentiation of benzodiazepine receptor binding by ethylenediamine analogues and derivatives. Br J Pharmacol (1983) 0.82
gamma-Aminobutyric acid and benzodiazepine receptors: copurification and characterization. Proc Natl Acad Sci U S A (1981) 0.82
Interaction of calcium channel blockers with non-neuronal benzodiazepine binding sites. Proc Natl Acad Sci U S A (1984) 0.82
Histidine modification with diethyl pyrocarbonate shows heterogeneity of benzodiazepine receptors. Proc Natl Acad Sci U S A (1981) 0.81
Anticonvulsant actions of the putative gamma-aminobutyric acid (GABA)-mimetic, ethylenediamine. Br J Pharmacol (1982) 0.81
Calcium channels: evidence for oligomeric nature by target size analysis. EMBO J (1983) 0.80
Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment. PLoS One (2013) 0.78
Pharmacology of the benzodiazepine receptor. Eur Arch Psychiatry Neurol Sci (1989) 0.78
Phosphorylation induces a decrease in the biological activity of the protein inhibitor (GABA-modulin) of gamma-aminobutyric acid binding sites. Proc Natl Acad Sci U S A (1983) 0.78
Effects of benzodiazepines and barbiturates in a GABA-dependent animal model: interactions with muscimol in the globus pallidus [proceedings]. Br J Pharmacol (1979) 0.75
Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. 1983. Br J Pharmacol (1997) 0.75
Increase in the Bmax of gamma-aminobutyric acid-A recognition sites in brain regions of mice receiving diazepam. Proc Natl Acad Sci U S A (1984) 0.75
Evaluating molecular similarity using reduced representations of the electron density. J Mol Model (2005) 0.75
The concept of access: definition and relationship to consumer satisfaction. Med Care (1981) 10.22
Increasing Medicare enrollment in HMOs: the need for capitation rates adjusted for health status. Inquiry (1983) 3.21
Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet (1999) 3.15
Functional health measure for adjusting health maintenance organization capitation rates. Health Care Financ Rev (1986) 2.63
NHLBI plans for the promise of cell-based therapies. Cytotherapy (2005) 2.04
Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease. N Engl J Med (1973) 1.94
Including health status in Medicare's Adjusted Average Per Capita Cost capitation formula. Med Care (1986) 1.88
Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families. J Immunol (1989) 1.88
Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science (1980) 1.76
Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390. Neuroscience (1991) 1.74
Immune response gene control of determinant selection. III. Polypeptide fragments of insulin are differentially recognized by T but not by B cells in insulin immune guinea pigs. J Immunol (1981) 1.71
Possible proton relay pathways in cytochrome c oxidase. Proc Natl Acad Sci U S A (1995) 1.62
Isolation and relationship of human hexosaminidases. J Biol Chem (1974) 1.61
Insight into the active-site structure and function of cytochrome oxidase by analysis of site-directed mutants of bacterial cytochrome aa3 and cytochrome bo. J Bioenerg Biomembr (1993) 1.49
B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J Immunol (2001) 1.45
Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. J Neurosci (1990) 1.43
Mepacrine blocks beta-adrenergic agonist-induced desensitization in astrocytoma cells. Proc Natl Acad Sci U S A (1980) 1.31
The cytochrome oxidase superfamily of redox-driven proton pumps. Trends Biochem Sci (1994) 1.28
Relating satisfaction with access to utilization of services. Med Care (1984) 1.24
Selection bias in TEFRA at-risk HMOs. Med Care (1991) 1.23
Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J Pharmacol Exp Ther (1988) 1.23
The GABA-ergic system: a locus of benzodiazepine action. Annu Rev Neurosci (1985) 1.17
Medical students' knowledge and misconceptions about aging: responses to Palmore's Facts on Aging Quizzes. Gerontologist (1992) 1.17
Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology (1997) 1.17
Anergy and not clonal ignorance determines the fate of B cells that recognize a physiological autoantigen. J Immunol (2001) 1.16
Autoimmune pancreatitis results from loss of TGFbeta signalling in S100A4-positive dendritic cells. Gut (2009) 1.16
Induction of functional beta-adrenergic receptors in HeLa cells. Proc Natl Acad Sci U S A (1977) 1.15
Chromosome-wide linkage disequilibrium caused by an inversion polymorphism in the white-throated sparrow (Zonotrichia albicollis). Heredity (Edinb) (2010) 1.14
Clinical and sociodemographic risk factors for readmission of Medicare beneficiaries. Health Care Financ Rev (1988) 1.14
In vitro lymphocyte responses and skin test reactivity following BCG vaccination. Clin Exp Immunol (1971) 1.13
Benzodiazepine and beta-adrenergic receptor ligands independently stimulate phospholipid methylation. Nature (1980) 1.11
Ganglioside catabolism in hexosaminidase A-deficient adults. Nature (1974) 1.10
Defining hospital clusters and associated service communities in metropolitan areas. Socioecon Plann Sci (1981) 1.09
Benefits derived from routine testing for milk ketones. J Dairy Sci (1968) 1.09
Computational and experimental analyses reveal previously undetected coding exons of the KRIT1 (CCM1) gene. Genomics (2001) 1.08
A study of the two-filter method for radon-222. Health Phys (1970) 1.06
Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol Pharmacol (1988) 1.06
Effect of antipsychotic drugs on the firing of dorsal raphe cells. II. Reversal by picrotoxin. Eur J Pharmacol (1976) 1.06
Lymphocyte transformation by phytohemagglutinin. I. In Hodgkin's Disease. Can Med Assoc J (1967) 1.05
H-2-linked Ir gene control of antibody responses to insulin. I. Anti-insulin plaque-forming cell primary responses. J Immunol (1979) 1.05
Deficient Ganglioside Biosynthesis: a novel human sphingolipidosis. Science (1975) 1.04
Including a measure of health status in Medicare's health maintenance organization capitation formula: reliability issues. Med Care (1987) 1.03
Lymphocyte transformation by phytohemagglutinin. II. In the tuberculous patient. Can Med Assoc J (1967) 1.03
Enzymic activities associated with membranous cytoplasmic bodies and isolated brain lysosomes. J Neurochem (1971) 1.02
Benzodiazepines: potentiation of a GABA inhibitory response in the dorsal raphe nucleus. Eur J Pharmacol (1978) 1.02
Determination of the ligands of the low spin heme of the cytochrome o ubiquinol oxidase complex using site-directed mutagenesis. J Biol Chem (1992) 1.01
Metabolic effects of dietary fructose and sucrose in types I and II diabetic subjects. JAMA (1986) 1.00
Chronic diazepam treatment produces regionally specific changes in GABA-stimulated chloride influx. Eur J Pharmacol (1989) 1.00
Guide-wire entrapment by inferior vena caval filters: in vitro evaluation. Radiology (1996) 0.99
Structural requirements for the specific recognition of an m7G mRNA cap. Biochemistry (2000) 0.99
Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus. J Immunol (1989) 0.99
Techniques for defining geographic boundaries for health regions. Socioecon Plann Sci (1979) 0.98
Chronic morphine administration increases the apparent number of alpha 2-adrenergic receptors in rat brain. Nature (1981) 0.98
Raphe origin of serotonergic nerves terminating in the cerebral ventricles. Brain Res (1975) 0.98
Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus. Proc Natl Acad Sci U S A (1990) 0.98
The low-spin heme site of cytochrome o from Escherichia coli is promiscuous with respect to heme type. Biochemistry (1992) 0.97
The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue. J Clin Invest (1972) 0.97
Recognition of common islet antigen by autoantibodies from NOD mice and humans with IDDM. Diabetes (1990) 0.97
Isolation of a human brain cDNA for glutamate dehydrogenase. J Neurochem (1987) 0.96
Regulation of G proteins by chronic morphine in the rat locus coeruleus. Brain Res (1989) 0.96
Modulation of protein kinase C translocation by excitatory and inhibitory amino acids in primary cultures of neurons. J Neurochem (1991) 0.95
Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects. N Engl J Med (1983) 0.95
Retinal hemangioblastoma. A histologic, immunohistochemical, and ultrastructural evaluation. Ophthalmology (1992) 0.95
Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity. Nature (1984) 0.95
Characterization of photoaffinity labeling of benzodiazepine binding sites. J Biol Chem (1981) 0.94
Effect of therapeutic irradiation on lymphocyte transformation in lung cancer. Cancer (1971) 0.94
Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study. Mol Psychiatry (1998) 0.93
Antigen processing and the human T cell receptor repertoire for insulin. J Immunol (1988) 0.93
Shortened platelet survival time and enhanced heart rate responses after abrupt withdrawal of propranolol from normal subjects. Am J Cardiol (1981) 0.93
Enzyme replacement therapy for the sphingolipidoses. Adv Exp Med Biol (1976) 0.93
"Lumps" and "bumps" that mimic acute aortic and brachiocephalic vessel injury. Radiographics (1997) 0.92
Catecholamine-induced desensitization of adenylate cyclase in rat glioma C6 cells. Evidence for a specific uncoupling of beta-adrenergic receptors from a functional regulatory component of adenylate cyclase. Mol Pharmacol (1981) 0.92
Measurement of radon daughters in air. Health Phys (1972) 0.91
Corticosterone differentially regulates the expression of Gs alpha and Gi alpha messenger RNA and protein in rat cerebral cortex. Proc Natl Acad Sci U S A (1989) 0.91
VH and VL gene usage by murine IgG antibodies that bind autologous insulin. J Immunol (1990) 0.91
Phosphorylation of the GABAa/benzodiazepine receptor alpha subunit by a receptor-associated protein kinase. J Neurochem (1988) 0.90
Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells. J Immunol (1999) 0.90
Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity. J Pharmacol Exp Ther (1996) 0.90
[3H]Diazepam binding in mammalian central nervous system: a pharmacological characterization. J Neurosci (1981) 0.90
Quantitative autoradiographic mapping of serotonin 5-HT1 and 5-HT2 receptors and uptake sites in the neocortex of the rhesus monkey. J Comp Neurol (1989) 0.90
ComboScreen facilitates the multiplex hybridization-based screening of high-density clone arrays. Bioinformatics (2000) 0.90
II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1. J Pharmacol Exp Ther (1997) 0.89
Isolation of a cDNA for rat brain glutaminase. Brain Res (1988) 0.89
A comparison of self-reported measures of perceived health and functional health in an elderly population. J Community Health (1987) 0.89
Kinetics of electron and proton transfer during the reaction of wild type and helix VI mutants of cytochrome bo3 with oxygen. Biochemistry (1996) 0.89
Determination of sialidase activities in HeLa cells using gangliosides specifically labeled in N-acetylneuraminic acid. Arch Biochem Biophys (1977) 0.89
Activation by autophosphorylation or cGMP binding produces a similar apparent conformational change in cGMP-dependent protein kinase. J Biol Chem (1998) 0.88
Glutamate-89 in subunit II of cytochrome bo3 from Escherichia coli is required for the function of the heme-copper oxidase. Biochemistry (1999) 0.88
Identity of the axial ligand of the high-spin heme in cytochrome oxidase: spectroscopic characterization of mutants in the bo-type oxidase of Escherichia coli and the aa3-type oxidase of Rhodobacter sphaeroides. Biochemistry (1993) 0.88
Changes in alpha- and beta-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressants. Neuropharmacology (1982) 0.88
Time course for development of anticonvulsant tolerance and GABAergic subsensitivity after chronic diazepam. Brain Res (1987) 0.87
The effects of gastric exclusion operations on pancreatic exocrine secretion. Surgery (1974) 0.87
Dexamethasone regulates glutamine synthetase expression in rat skeletal muscles. Am J Physiol (1988) 0.87
Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium. Nature (1978) 0.87
Effects of continuous diazepam administration on GABAA subunit mRNA in rat brain. J Mol Neurosci (1990) 0.87
Isolation of a novel endogenous opiate analgesic from human blood. Proc Natl Acad Sci U S A (1976) 0.87